Sign up to our newsletter Subscribe
Adrian Towse, currently President of ISPOR, contributed to two session at the recent ISPOR Asia-Pacific conference. Using HTA to maximise health system performance: Health technology assessment (HTA) is familiar as a technique for gauging the value of specific medical technologies…
Adrian Towse, currently President of ISPOR, contributed to two session at the recent ISPOR Asia-Pacific conference.
Balancing cost and access using managed entry agreements
High-cost, innovative pharmaceuticals are one serious challenge for health care systems today. At a panel that explored how this might be addressed in Asia, Adrian identified the issues and discussed the potential role of managed entry agreements (MEAs) and performance-based risk-sharing arrangements (PBRSAs). In essence, these measures allow a new medicine to be marketed while additional data about its use in actual clinical practice are being collected. Implementing MEAs or PBRSAs can be difficult, he notes. Crucial to success are assessing local value and ensuring that measures are based on formal written agreements about MEAs and PBRSAs that clearly set out expectations and responsibilities for all stakeholders.
For additional information on these topics, please contact Adrian Towse.
An error has occurred, please try again later.
